To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held
Committee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
Referred to the Subcommittee on Health.
Committee on Ways and Means discharged.
Committee on Ways and Means discharged.
Placed on the Union Calendar, Calendar No. 779.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line